Woodline Partners LP 10x Genomics, Inc. Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $3.8 Million - $5.72 Million	105,261 New	105,261 $3.95 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $6.17 Million - $9.52 Million	151,098 New	151,098 $6.23 Million
Q1 2023 May 15, 2023	SELL	$35.33 - $55.79 $5.04 Million - $7.97 Million	-142,784 Reduced 69.97%	61,270 $3.42 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $4.98 Million - $8.43 Million	204,054 New	204,054 $7.44 Million

292

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.48B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.